Cargando…
Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial
BACKGROUND: Epidermal growth factor receptor (EGFR) is highly expressed in adenoid cystic carcinoma (ACC). The efficacy and toxicity of cetuximab with concomitant platinum-based chemoradio- or chemotherapy in patients with locally advanced or metastatic ACC, respectively, was evaluated. METHODS: Eli...
Autores principales: | Hitre, E, Budai, B, Takácsi-Nagy, Z, Rubovszky, G, Tóth, E, Remenár, É, Polgár, C, Láng, I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778310/ https://www.ncbi.nlm.nih.gov/pubmed/23942070 http://dx.doi.org/10.1038/bjc.2013.468 |
Ejemplares similares
-
RadioImmunotherapy for adenoid cystic carcinoma: a single-institution series of combined treatment with cetuximab
por: Jensen, Alexandra D, et al.
Publicado: (2010) -
The prognostic value of chemotherapy or/and radiotherapy in adenoid cystic carcinoma and adenoid basal carcinoma of the uterine cervix
por: Liu, Kun, et al.
Publicado: (2022) -
Adenoid Cystic Carcinoma of Mandible
por: Santos, Thiago de Santana, et al.
Publicado: (2015) -
Adenoid Cystic Carcinoma of the Breast May Be Exempt from Adjuvant Chemotherapy
por: Li, Lixi, et al.
Publicado: (2022) -
Adenoid cystic carcinoma of palate
por: Mehta, Dhaval N., et al.
Publicado: (2013)